SLC22A4 Variants Influence Fusobacterium nucleatum in Colorectal Cancer
Variants of the SLC22A4 transporter affect the abundance of Fusobacterium nucleatum in colorectal cancer, linking genetic factors to microbiota composition.
Asset / Drug
Drug and asset intelligence for SLC22A4 with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.